Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

[1] Shelton J.D., Halperin D.T., Wilson D., Has global incidence peaked?, Lancet, 367, pp. 1120-1122, (2006)

[2] Auvert B., Taljaard D., Lagarde E., Sobngwi-Tambekou J., Sitta R., Et al., Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial, PLoS Med, 2, (2005)

[3] Gray R., Wawer M.J., Thoma M., Serwadda D., Nalugoda F., Et al., Male circumcision and the risks of female HIV and sexually transmitted infection acquisition in Rakai, Uganda, 13th Conference on Retroviruses and Opportunistic Infections, (2006)

[4] Dhawan D., Mayer K.H., Microbicides to prevent HIV transmission: Overcoming obstacles to chemical barrier protection, J Infect Dis, 193, pp. 36-44, (2006)

[5] Tsai C.-C., Emau P., Jiang Y., Tian B., Morton W.R., Et al., Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques, AIDS Res Hum Retroviruses, 19, pp. 535-541, (2003)

[6] Youle M., Wainberg M.A., Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?, AIDS, 17, pp. 937-938, (2003)

[7] Tsai C.-C., Follis K.E., Sabo A., Beck T., Grant R.F., Et al., Prevention of SIV Infection in Macaques by (R)-9(2- Phosphonylmethoxypropyl)adenine, Science, 270, pp. 1197-1199, (1995)

[8] Van Rompay K.K., McChesney M.B., Aguirre N.L., Schmidt K.A., Bischofberger N., Et al., Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection, J Infect Dis, 184, pp. 429-438, (2001)

[9] Veazey R.S., Springer M.S., Marx P.A., Dufour J., Klasse P.J., Et al., Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor, Nat Med, 11, pp. 1293-1294, (2005)

[10] Garcia-Lerma J.G., Otten R., Qari S.H., Jackson E., Luo W., Et al., Prevention of rectal SHIV transmission in macaques by tenofovir/FTC combination, 13th Conference on Retroviruses and Opportunistic Infections, (2006)

[1] Shelton J.D., Halperin D.T., Wilson D., Has global incidence peaked?, Lancet, 367, pp. 1120-1122, (2006)

[2] Auvert B., Taljaard D., Lagarde E., Sobngwi-Tambekou J., Sitta R., Et al., Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial, PLoS Med, 2, (2005)

[3] Gray R., Wawer M.J., Thoma M., Serwadda D., Nalugoda F., Et al., Male circumcision and the risks of female HIV and sexually transmitted infection acquisition in Rakai, Uganda, 13th Conference on Retroviruses and Opportunistic Infections, (2006)

[4] Dhawan D., Mayer K.H., Microbicides to prevent HIV transmission: Overcoming obstacles to chemical barrier protection, J Infect Dis, 193, pp. 36-44, (2006)

[5] Tsai C.-C., Emau P., Jiang Y., Tian B., Morton W.R., Et al., Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques, AIDS Res Hum Retroviruses, 19, pp. 535-541, (2003)

[6] Youle M., Wainberg M.A., Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?, AIDS, 17, pp. 937-938, (2003)

[7] Tsai C.-C., Follis K.E., Sabo A., Beck T., Grant R.F., Et al., Prevention of SIV Infection in Macaques by (R)-9(2- Phosphonylmethoxypropyl)adenine, Science, 270, pp. 1197-1199, (1995)

[8] Van Rompay K.K., McChesney M.B., Aguirre N.L., Schmidt K.A., Bischofberger N., Et al., Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection, J Infect Dis, 184, pp. 429-438, (2001)

[9] Veazey R.S., Springer M.S., Marx P.A., Dufour J., Klasse P.J., Et al., Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor, Nat Med, 11, pp. 1293-1294, (2005)

[10] Garcia-Lerma J.G., Otten R., Qari S.H., Jackson E., Luo W., Et al., Prevention of rectal SHIV transmission in macaques by tenofovir/FTC combination, 13th Conference on Retroviruses and Opportunistic Infections, (2006)